40896-62-6

Basic information

• Product Name: [3-(aMinoMethyl)phenyl]Methanol hydrochloride (SALTDATA: HCl)
• Synonyms: [3-(aMinoMethyl)phenyl]Methanol hydrochloride (SALTDATA: HCl);(3-(Aminomethyl)phenyl)methanol hydrochloride
• CAS NO: 40896-62-6
• Molecular Formula: C₈H₁₁NO*ClH
• Molecular Weight: 173.63998
• Mol File: 40896-62-6.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: [3-(aMinoMethyl)phenyl]Methanol hydrochloride (SALTDATA: HCl)(CAS DataBase Reference)
• NIST Chemistry Reference: [3-(aMinoMethyl)phenyl]Methanol hydrochloride (SALTDATA: HCl)(40896-62-6)
• EPA Substance Registry System: [3-(aMinoMethyl)phenyl]Methanol hydrochloride (SALTDATA: HCl)(40896-62-6)

Safety Data

• Statements: 41
• Safety Statements: 26-39
• Hazardous Substances Data: 40896-62-6(Hazardous Substances Data)

Usage

General Description

[3-(aMinoMethyl)phenyl]Methanol hydrochloride (SALTDATA: HCl) is a chemical compound with the molecular formula C8H11NO.HCl. It is a white crystalline powder that is commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs and pharmaceutical intermediates. It is also used as a reagent in organic chemistry reactions. The hydrochloride salt form of [3-(aMinoMethyl)phenyl]Methanol makes it more stable and soluble in water, making it easier to handle and work with in laboratory settings. It is important to handle this compound carefully as it can be harmful if ingested, inhaled, or comes into contact with skin.

Upstream product

• 874-97-5 3-(hydroxymethyl)benzonitrile 
• 226070-69-5 1,1-dimethylethyl {[3-(hydroxymethyl)phenyl]methyl}carbamate 

Downstream Products

• 743461-27-0 biphenyl-2-ylcarbamic Acid 1-{2-[3-(3-Hydroxymethylbenzyl)ureido]ethyl}piperidin-4-yl Ester 
• 1361952-84-2 2-((S)-1-{2-[3-(3-hydroxymethylbenzyl)ureido]ethyl}pyrrolidin-3-yl)-2,2-diphenylacetamide 

Relevant articles and documents

Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

The invention is directed to compounds of formula I: wherein R1, R2, R3, R4, R5, R6, R7a, R7b, W, G1, G2, a, b, c, d and m are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.

Azabicycloalkane compounds

This invention provides compounds of formula I: wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The compounds of this invention possess both β2 adrenergic receptor agonist and muscarinic receptor antagonist activity. Such compounds are useful for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.

Substituent effects. 14. Anomalous dissociation constants in water-organic solvent mixtures: benzylammonium ions and related systems

Thermodynamic dissociation constants in various water-organic solvent mixtures are given for benzylammonium, benzyldialkylammonium, and (2-phenylethyl)ammonium ions.Deviations from the Hammett equation (Eqn. 1) are similar to those observed for carboxylic acids, but of opposite sign.The extended Hammett equation (Eqn. 3), containing the hydrophobic constant, ?, yields good correlations.Derived secondary normal sigma values are exemplified.